Clinical Trial Update: Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immune response of an RSV vaccine across adults, RSV-seropositive children, and RSV-seronegative infants and children; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED